Literature DB >> 35759079

Soluble ST2: a valuable prognostic marker in heart failure.

Sugeevan Savarimuthu1, Pavan Goel2, Amer Harky3.   

Abstract

Natriuretic peptides have been at the forefront of biomarker use in heart disease and have been universally recommended as the ideal biomarker in the setting of heart failure. Soluble ST2 is one such biomarker which has found value as a prognostic marker and can be used individually or along with natriuretic peptides in order to prognosticate patients with heart failure. Leading cardiovascular organisations have recognised this biomarker, though its role as a diagnostic marker is yet to be determined. We aim to investigate the role of sST2 in heart failure in the existing literature.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Biomarker; Heart failure; Natriuretic peptide; Soluble ST2

Mesh：

Substances：

Year:  2022        PMID： 35759079     DOI： 10.1007/s10741-022-10258-2

Source DB:  PubMed          Journal:  Heart Fail Rev        ISSN： 1382-4147            Impact factor:   4.654


  20 in total

1.  Soluble ST2 as a Diagnostic and Prognostic Marker for Acute Heart Failure Syndromes.

Authors:  Queen Henry-Okafor; Sean P Collins; Cathy A Jenkins; Karen F Miller; David J Maron; Allen J Naftilan; Neal Weintraub; Gregory J Fermann; John McPherson; Santosh Menon; Douglas B Sawyer; Alan B Storrow
Journal:  Open Biomark J       Date:  2012-04-20

2.  Soluble ST2 and brain natriuretic peptide predict different mode of death in patients with heart failure and preserved ejection fraction.

Authors:  Akinori Sugano; Yoshihiro Seo; Tomoko Ishizu; Seika Sai; Masayoshi Yamamoto; Yoshie Hamada-Harimura; Tomoko Machino-Ohtsuka; Kenichi Obara; Isao Nishi; Kazutaka Aonuma; Akihiko Nogami
Journal:  J Cardiol       Date:  2018-12-20       Impact factor: 3.159

3.  High-sensitivity ST2 for prediction of adverse outcomes in chronic heart failure.

Authors:  Bonnie Ky; Benjamin French; Kristin McCloskey; J Eduardo Rame; Erin McIntosh; Puja Shahi; Daniel L Dries; W H Wilson Tang; Alan H B Wu; James C Fang; Rebecca Boxer; Nancy K Sweitzer; Wayne C Levy; Lee R Goldberg; Mariell Jessup; Thomas P Cappola
Journal:  Circ Heart Fail       Date:  2010-12-22       Impact factor: 8.790

4.  Soluble ST2, high-sensitivity troponin T- and N-terminal pro-B-type natriuretic peptide: complementary role for risk stratification in acutely decompensated heart failure.

Authors:  Domingo A Pascual-Figal; Sergio Manzano-Fernández; Miguel Boronat; Teresa Casas; Iris P Garrido; Juan C Bonaque; Francisco Pastor-Perez; Mariano Valdés; James L Januzzi
Journal:  Eur J Heart Fail       Date:  2011-05-06       Impact factor: 15.534

5.  Usefulness of soluble concentrations of interleukin family member ST2 as predictor of mortality in patients with acutely decompensated heart failure relative to left ventricular ejection fraction.

Authors:  Sergio Manzano-Fernández; Thomas Mueller; Domingo Pascual-Figal; Quynh A Truong; James Louis Januzzi
Journal:  Am J Cardiol       Date:  2011-01-15       Impact factor: 2.778

6.  Prognostic Value of Baseline and Changes in Circulating Soluble ST2 Levels and the Effects of Nesiritide in Acute Decompensated Heart Failure.

Authors:  W H Wilson Tang; Yuping Wu; Justin L Grodin; Amy P Hsu; Adrian F Hernandez; Javed Butler; Marco Metra; Adriaan A Voors; G Michael Felker; Richard W Troughton; Roger M Mills; John J McMurray; Paul W Armstrong; Christopher M O'Connor; Randall C Starling
Journal:  JACC Heart Fail       Date:  2015-12-02       Impact factor: 12.035

7.  sST2 Predicts Outcome in Chronic Heart Failure Beyond NT-proBNP and High-Sensitivity Troponin T.

Authors:  Michele Emdin; Alberto Aimo; Giuseppe Vergaro; Antoni Bayes-Genis; Josep Lupón; Roberto Latini; Jennifer Meessen; Inder S Anand; Jay N Cohn; Jørgen Gravning; Lars Gullestad; Kaspar Broch; Thor Ueland; Ståle H Nymo; Hans-Peter Brunner-La Rocca; Rudolf A de Boer; Hanna K Gaggin; Andrea Ripoli; Claudio Passino; James L Januzzi
Journal:  J Am Coll Cardiol       Date:  2018-11-06       Impact factor: 24.094

8.  ST2 in patients with severe aortic stenosis and heart failure.

Authors:  Andrew Cai; Alejandra Miyazawa; Nicholas Sunderland; Susan E Piper; Thomas G J Gibbs; Duolao Wang; Sadie Redding; George Amin-Youseff; Olaf Wendler; Jonathan Byrne; Philip A MacCarthy; Ajay M Shah; Theresa A McDonagh; Rafał Dworakowski
Journal:  Cardiol J       Date:  2019-06-21       Impact factor: 2.737

Review 9.  Soluble ST2 Testing: A Promising Biomarker in the Management of Heart Failure.

Authors:  Humberto Villacorta; Alan S Maisel
Journal:  Arq Bras Cardiol       Date:  2016-01-15       Impact factor: 2.000

10.  Prognostic value of serum soluble ST2 in stable coronary artery disease: a prospective observational study.

Authors:  Hack-Lyoung Kim; Jung Pyo Lee; Nathan Wong; Woo-Hyun Lim; Jae-Bin Seo; Joo-Hee Zo; Myung-A Kim; Sang-Hyun Kim
Journal:  Sci Rep       Date:  2021-07-26       Impact factor: 4.379
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.